Curatis identifies potential drug candidates in indications with high unmet medical need via its extensive network within the scientific and medical community and the biotech/pharmaceutical industry. Curatis significantly invests in its development projects. Curatis' strategy is to identify compounds for which safety and clinical efficacy data already exist, enabling faster development with lower risk and investment through to commercialization.